None listed
Conditions
Interventions
Medical Device : If you participate in a clinical trial and meet the selection exclusion criteria, the test device (Holter electrocardiograph (HEH001, HEE005)) and the control device (FUKUDA DENSHI el
Sponsors
Cheonan Korean Medicine Hospital of Daejeon University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults between 19 and 75 years of age 2) Those who voluntarily agreed in writing to participate in this clinical trial
Exclusion criteria
Exclusion criteria: 1) Those with skin allergies, skin conditions that make lead attachment difficult, or those being treated for these conditions, those with chest wall deformities, or those with recent skin trauma to the chest. 2) Uncontrolled mental illness, alcoholics 3) Those who received intervention among those who participated in other clinical studies within 1 month of the screening visit 4) Pregnant or lactating women 5) Persons judged by the researcher to be inappropriate to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate: Number of heartbeats per unit time | — |
Secondary
| Measure | Time frame |
|---|---|
| RR interval(seconds) : Time from the top of the R wave to the top of the next R wave;QRS interval (seconds): Time from the beginning of the Q wave to the end of the S wave;PR interval (seconds): Time from the start of the P wave to the start of the QRS complex;QT interval (seconds): Time from the beginning of the QRS complex to the end of the T wave;QTc interval (seconds): Corrected QT interval;Axis (degree): QRS axis in the direction of ventricular electrical flow when viewed from the front. | — |
Countries
Korea, Republic of
Contacts
Public ContactJae Hui Kang
Cheonan Korean Medicine Hospital of Daejeon University
Outcome results
None listed